In the BioHarmony Drug Report Database

"Preview" Icon

Padeliporfin

Tookad (padeliporfin) is a small molecule pharmaceutical. Padeliporfin was first approved as Tookad on 2017-11-10. It has been approved in Europe to treat prostatic neoplasms.

 

Trade Name

 

Tookad
 

Common Name

 

padeliporfin
 

ChEMBL ID

 

CHEMBL4594284
 

Indication

 

prostatic neoplasms
 

Drug Class

 

Benzoporphyrin derivatives

Image (chem structure or protein)

Padeliporfin structure rendering